Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026)

Senseonics Holdings' (SENS) quarterly Net Income towards Common Stockholders came in at -$41.0 million in Q1 2026, down 91.26% year-on-year from -$468.7 million in Q1 2025, and down 96.78% on a QoQ basis from -$20.8 million in Q4 2025.

Senseonics Holdings (SENS) Net Income towards Common Stockholders (2015 - 2026) Analysis & Trends

Senseonics Holdings (SENS) has 12 years of Net Income towards Common Stockholders data on file, last reported at -$41.0 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 91.26% year-over-year to -$41.0 million in Q1 2026; TTM through Mar 2026 was -$110.0 million, a 29.12% decrease from a year earlier, with the FY2025 full-year figure at -$72.0 million, up 8.56% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$41.0 million, down from -$20.8 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for SENS reached as high as -$10.7 million in Q4 2022 and fell as low as -$41.0 million in Q1 2026.
  • Historically, Net Income towards Common Stockholders has averaged -$22.2 million across 5 years, with a median of -$21.4 million in 2025.
  • Across the five-year window, Net Income towards Common Stockholders surged 62.14% in 2022 and slumped 91.26% in 2026, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$10.7 million in 2022, then slumped by 61.89% to -$17.2 million in 2023, then soared by 32.27% to -$11.7 million in 2024, then tumbled by 78.26% to -$20.8 million in 2025, then tumbled by 96.78% to -$41.0 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$41.0 million in Q1 2026, -$20.8 million in Q4 2025, and -$26.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 Senseonics Holdings 229.57 Mn 165.25 Mn 6.94 Mn -40.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -40.96 Mn
Dec 31, 2025 -20.82 Mn
Sep 30, 2025 -26.50 Mn
Jun 30, 2025 -21.72 Mn
Mar 31, 2025 -21.42 Mn
Dec 31, 2024 -11.68 Mn
Sep 30, 2024 -30.90 Mn
Jun 30, 2024 -21.19 Mn
Mar 31, 2024 -18.90 Mn
Dec 31, 2023 -17.24 Mn
Sep 30, 2023 -27.59 Mn
Jun 30, 2023 -22.01 Mn
Mar 31, 2023 -23.25 Mn
Dec 31, 2022 -10.65 Mn
Sep 30, 2022 -21.83 Mn
Jun 30, 2022 -21.31 Mn
Mar 31, 2022 -19.56 Mn
Dec 31, 2021 -28.14 Mn
Sep 30, 2021 -19.79 Mn
Jun 30, 2021 -19.68 Mn